Blood test for fibrosis in rheumatoid arthritis and scleroderma
Part of Bones, joints & muscles, Immune system & allergy, Lungs & breathing, Skin clinical trials.
This study looks at whether a blood test can measure a protein linked to tissue scarring in people with rheumatoid arthritis or scleroderma. It aims to find a simpler way to track disease activity.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with rheumatoid arthritis or scleroderma.
- You are willing to give a blood sample and answer some questions.
- You do not have cancer or a history of cancer in the past 5 years.
- You are not pregnant or breastfeeding.
- You do not have other autoimmune diseases or major fibrotic conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether certain proteins (MMP-7 and MMP-9) in the blood can help identify lung problems in people with rheumatoid arthritis. It involves examining the tiny blood vessels at the base of your fingernails to see if they relate to these proteins.
This study is testing a new blood test that may help diagnose rheumatoid arthritis (RA) by detecting a specific antibody. If it works, it could lead to earlier and more accurate diagnosis.
This study tests a new way to find early signs of lung scarring (interstitial lung disease) in people with rheumatoid arthritis or scleroderma using a blood test and a lung ultrasound. It may help detect lung problems earlier, when treatment could be more effective.
This study uses a special skin scanner to measure sugar-related damage in the body, which may be linked to inflammation. It compares people with rheumatic conditions to healthy volunteers to see if the scanner can help track or predict disease.
This study follows different groups of people—from those at high risk of developing rheumatoid arthritis to those recently diagnosed—to learn more about the disease. By joining, you help researchers understand who gets RA and why, which may lead to earlier detection and better care.
This study looks at how a new drug affects skin scarring (fibrosis) in people with systemic sclerosis (SSc), a rare autoimmune disease. It aims to understand if this drug can help reduce the skin thickening and immune changes caused by SSc.
Hear when a new Systemic Sclerosis (SSc) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.